US Broker Ratings

Abbott Laboratories (ABT) Stock Analysis: Analyst Consensus Reveals a 10.96% Upside Potential

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector with a focus on medical devices, presents a compelling opportunity for investors seeking stability and growth...

Humana Inc. (HUM) Stock Analysis: Navigating a 4.25% Upside Amid Healthcare Growth

Humana Inc. (NYSE: HUM), a titan in the U.S. healthcare plans sector, presents a compelling proposition for investors seeking stability and growth in the healthcare industry...

Moderna, Inc. (MRNA) Stock Analysis: Is the Biotech Giant’s Market Cap Justified Amid a 19.96% Potential Downside?

Moderna, Inc. (MRNA), a leading figure in the biotechnology sector, has captivated investor attention with its robust portfolio of messenger RNA medicines. Despite its current standing..

Penumbra, Inc. (PEN): Growth Potential Amidst Analyst Consensus and Market Dynamics

For investors eyeing opportunities in the medical device sector, Penumbra, Inc. (PEN) presents a compelling case with its innovative product lineup and robust market presence. With..

Amgen Inc. (AMGN) Stock Analysis: Evaluating the Dividend Potential and Analyst Ratings in a Competitive Market

Amgen Inc. (NASDAQ: AMGN), a leading player in the healthcare sector, continues to capture investor attention with its robust portfolio of human therapeutics and a significant..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A Strong Buy with 13.23% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI) has established itself as a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. With..

ResMed Inc. (RMD) Stock Analysis: Navigating a 7.78% Upside Potential in the Healthcare Sector

ResMed Inc. (RMD), a prominent player in the healthcare sector, has garnered investor attention with its robust market presence in the medical instruments and supplies industry...

Charles River Laboratories Inte (CRL): Analyst Consensus and Growth Potential Amidst Market Volatility

Charles River Laboratories International, Inc. (CRL) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization..

Elevance Health, Inc. (ELV) Stock Analysis: Evaluating a 10% Upside Potential

Elevance Health, Inc. (NYSE: ELV) stands as a formidable player in the healthcare plans industry, with a significant market capitalization of $88.37 billion. As a prominent..

Doximity, Inc. (DOCS) Stock Analysis: Navigating a 13% Potential Upside Amidst Healthcare Innovation

Doximity, Inc. (NYSE: DOCS) is a compelling player in the healthcare sector, particularly within the Health Information Services industry. With a market capitalization of $4.7 billion,..

Bristol-Myers Squibb (BMY): Investor Outlook with a Focus on Dividend Yield and Strategic Collaborations

Bristol-Myers Squibb Company (NYSE: BMY), a leading player in the healthcare sector, continues to captivate investors with its robust dividend yield and strategic collaborations. As a..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Biotech Powerhouse with a Revenue Growth of 47.70%

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is making waves in the biotechnology sector with its impressive revenue growth of 47.70%, reflecting its strong market presence and innovative..

The Ensign Group, Inc. (ENSG) Stock Analysis: A 28.81% Upside Potential Beckons Investors

For investors seeking opportunities in the healthcare sector, The Ensign Group, Inc. (NASDAQ: ENSG) presents a compelling case with its robust business model and significant growth..

Edwards Lifesciences (EW) Stock Analysis: Exploring a 12.3% Upside in the Medical Devices Sector

Investors in the healthcare sector are paying close attention to Edwards Lifesciences Corporation (NYSE: EW), a leading player in the medical devices industry. With a market..

Baxter International Inc. (BAX) Stock Analysis: Exploring Potential Upside and Analyst Ratings

Baxter International Inc. (NYSE: BAX), a prominent player in the healthcare sector, offers a diverse portfolio of medical instruments and supplies. With a market capitalization of..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Exploring a 9.69% Potential Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the medical devices industry, offers an intriguing opportunity for investors looking to capitalize on growth within..

Zoetis Inc. (ZTS) Investor Outlook: Unlocking a 26.63% Upside Potential in the Healthcare Sector

Zoetis Inc. (ZTS), a formidable player in the healthcare sector specializing in animal health, is a company that has captured the attention of investors with its..

ICON plc (ICLR) Stock Report: Evaluating a 12.56% Potential Upside Amidst Healthcare Sector Expansion

ICON plc (NASDAQ: ICLR), a prominent player in the healthcare sector, particularly within the diagnostics and research industry, is drawing significant attention from investors. Headquartered in..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Discovering the 19.26% Potential Upside in Precision Oncology

Revolution Medicines, Inc. (NASDAQ: RVMD) has recently captured the attention of the investment community, not only for its groundbreaking work in the biotechnology sector but also..

Cardinal Health, Inc. (CAH): Investor Outlook on a Healthcare Giant with a 9.61% Potential Upside

Cardinal Health, Inc. (NYSE: CAH) stands as a formidable player in the healthcare sector, specifically within the medical distribution industry. With a substantial market capitalization of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds